Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RO5186582 multiple-dose pharmacokinetics, metabolism, and excretion study in healthy male volunteers
NL-OMON36981Phase 1Active, not recruiting
- Sponsor
- Roche
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of basmisanil in Down syndrome, sponsored by Roche. Primary endpoints: Plasma levels of RO5186582 and metabolites, Absolute oral bioavailability of RO5186582 and 1 more. Started Aug 2012; status: active, not recruiting.
02
Drugs
basmisanil
03
Conditions
Down syndrome
Beyond the preview
Go deeper on NL-OMON36981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36981.